Yu-Ning Wong, MD, MSCE


 

Yu-Ning Wong, MD, MSCE, is assistant professor, Fox Chase Cancer Center and adjunct senior fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA and an editorial board member for Value-Based Cancer Care.

Authored Items

The $93,000 Question

September 2010, Vol 1, No 4 - VBCC Perspectives

Sipuleucel-T (Provenge) and cabazitaxel (Jevtana) have drawn much attention both for being the first new treatments for advanced prostate cancer since docetaxel (Taxotere) was approved in 2004, and for their high costs. As described in Dr Newcomer’s accompanying piece, they will add significantly to the cost of care [ Read More ]